Key Insights

Highlights

Success Rate

80% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

8.3%

1 terminated out of 12 trials

Success Rate

80.0%

-6.5% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results80% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (12)

Trial Status

Recruiting4
Completed4
Terminated1
Not Yet Recruiting1
Withdrawn1
Unknown1

Trial Success Rate

80.0%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (12)

Research Network

Activity Timeline